Company · CIK 0000906709 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NEKTAR THERAPEUTICS · NKTR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2018 MForm 4 → | Jan 24, 6:01 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | $11.34 | $944,996 | 333,268 | — | plan? |
| Jan 4, 2018 MForm 4 → | Jan 8, 6:07 pm EST | Dennis L WingerDirector | 33,750 | $11.97 | $403,988 | 77,000 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 4, 6:01 pm EST | Christopher A KueblerDirector | 30,000 | $58.66 | $1,759,800 | 40,500 | −42.6% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 4, 6:01 pm EST | Christopher A KueblerDirector | 30,000 | $14.26 | $427,800 | 70,500 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:29 pm EST | Howard W RobinPresident & CEO, Director | 60,500 | — | — | 249,935 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:28 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 10,400 | — | — | 71,402 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:28 pm EST | John NicholsonSVP & Chief Operating Officer | 26,000 | — | — | 272,536 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:27 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 26,000 | — | — | 103,216 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:26 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 15,000 | — | — | 83,136 | — | plan? |
| Dec 15, 2017 AForm 4 → | Dec 19, 6:25 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 26,000 | — | — | 69,820 | — | plan? |
| Dec 13, 2017 SForm 4 → | Dec 15, 6:00 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | $55.69 | $4,640,815 | 189,435 | −30.6% | plan? |
| Dec 13, 2017 MForm 4 → | Dec 15, 6:00 pm EST | Howard W RobinPresident & CEO, Director | 83,333 | $11.34 | $944,996 | 272,768 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 20,289 | $44.23 | $233,932 | 60,549 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:06 pm EST | Howard W RobinPresident & CEO, Director | 73,069 | $44.23 | $799,192 | 189,435 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:05 pm EST | John NicholsonSVP & Chief Operating Officer | 26,620 | $44.23 | $292,803 | 246,536 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:05 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 26,698 | $44.23 | $296,253 | 76,716 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:04 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 20,597 | $44.23 | $247,555 | 67,636 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:03 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 25,022 | $44.23 | $222,123 | 56,553 | — | plan? |
| Nov 15, 2017 ADForm 4 → | Nov 17, 6:03 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 22,282 | $44.23 | $211,508 | 43,820 | — | plan? |
| Nov 13, 2017 SForm 4 → | Nov 15, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 15,910 | $37.78 | $601,080 | 233,156 | −6.39% | plan? |
| Nov 13, 2017 MForm 4 → | Nov 15, 6:02 pm EST | John NicholsonSVP & Chief Operating Officer | 25,000 | $9.24 | $231,000 | 249,066 | — | plan? |
| Nov 6, 2017 SForm 4 → | Nov 8, 6:02 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 5,117 | $25.07 | $128,283 | 58,233 | −8.08% | plan? |
| Nov 6, 2017 MForm 4 → | Nov 8, 6:02 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 39,717 | $17.15 | $680,961 | 58,233 | — | plan? |
| Nov 6, 2017 SForm 4 → | Nov 8, 6:01 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 396,323 | $29.00 | $11,493,476 | 31,102 | −92.7% | plan? |
| Nov 6, 2017 MForm 4 → | Nov 8, 6:01 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 396,323 | $9.53 | $3,776,958 | 331,102 | — | plan? |
| Nov 1, 2017 SForm 4 → | Nov 3, 6:07 pm EDT | Howard W RobinPresident & CEO, Director | 83,334 | $23.57 | $1,964,182 | 152,504 | −35.3% | plan? |
| Nov 1, 2017 MForm 4 → | Nov 3, 6:07 pm EDT | Howard W RobinPresident & CEO, Director | 83,334 | $11.34 | $945,008 | 235,838 | — | plan? |
| Oct 9, 2017 SForm 4 → | Oct 10, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | $24.20 | $2,016,659 | 152,504 | −35.3% | plan? |
| Oct 9, 2017 MForm 4 → | Oct 10, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | $11.34 | $944,996 | 235,837 | — | plan? |
| Oct 5, 2017 SForm 4 → | Oct 10, 6:07 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 7,583 | $25.00 | $189,575 | 58,233 | −11.5% | plan? late |
| Oct 5, 2017 MForm 4 → | Oct 10, 6:07 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 7,583 | $10.69 | $81,062 | 65,816 | — | plan? late |
| Oct 5, 2017 SForm 4 → | Oct 10, 6:06 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 43,677 | $24.97 | $1,090,615 | 31,102 | −58.4% | plan? late |
| Oct 5, 2017 MForm 4 → | Oct 10, 6:06 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 43,677 | $9.53 | $416,242 | 74,779 | — | plan? late |
| Oct 2, 2017 SForm 4 → | Oct 3, 6:06 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 120,000 | $24.45 | $2,934,000 | 63,414 | −65.4% | plan? |
| Oct 2, 2017 MForm 4 → | Oct 3, 6:06 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 120,000 | $11.34 | $1,360,800 | 183,414 | — | plan? |
| Sep 29, 2017 SForm 4 → | Oct 3, 6:02 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 100,000 | $24.14 | $2,413,640 | 41,575 | −70.6% | plan? |
| Sep 29, 2017 MForm 4 → | Oct 3, 6:02 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 100,000 | $11.04 | $1,104,000 | 98,279 | — | plan? |
| Sep 22, 2017 SForm 4 → | Sep 25, 6:04 pm EDT | Lutz LingnauDirector | 5,000 | $21.97 | $109,850 | 27,450 | −15.4% | plan? |
| Sep 22, 2017 SForm 4 → | Sep 25, 6:03 pm EDT | Christopher A KueblerDirector | 4,000 | $21.86 | $87,440 | 40,500 | −8.99% | plan? |
| Sep 21, 2017 SForm 4 → | Sep 25, 6:02 pm EDT | Robert ChessDirector | 6,400 | $21.72 | $139,008 | 274,223 | −2.28% | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 5:02 pm EDT | Jeffrey Robert AjerDirector | 22,500 | — | — | 22,500 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:57 pm EDT | Dennis L WingerDirector | 9,000 | — | — | 43,250 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:56 pm EDT | Christopher A KueblerDirector | 9,000 | — | — | 44,500 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:51 pm EDT | Roy A WhitfieldDirector | 9,000 | — | — | 142,000 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:49 pm EDT | Lutz LingnauDirector | 9,000 | — | — | 32,450 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:46 pm EDT | Joseph J KrivulkaDirector | 9,000 | — | — | 82,000 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:43 pm EDT | R Scott GreerDirector | 9,000 | — | — | 130,333 | — | plan? |
| Sep 19, 2017 AForm 4 → | Sep 21, 4:40 pm EDT | Robert ChessDirector | 9,000 | — | — | 280,623 | — | plan? |
| Sep 6, 2017 SForm 4 → | Sep 8, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | $21.54 | $1,794,993 | 152,504 | −35.3% | plan? |
| Sep 6, 2017 MForm 4 → | Sep 8, 6:08 pm EDT | Howard W RobinPresident & CEO, Director | 83,333 | $11.34 | $944,996 | 235,837 | — | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:05 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 2,648 | $19.32 | $51,159 | 50,838 | −4.95% | plan? |
| Aug 16, 2017 MForm 4 → | Aug 18, 7:05 pm EDT | Howard W RobinPresident & CEO, Director | 83,334 | $11.34 | $945,008 | 235,838 | — | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:05 pm EDT | Howard W RobinPresident & CEO, Director | 91,714 | $19.26 | $1,766,081 | 152,504 | −37.6% | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:04 pm EDT | John NicholsonSVP & Chief Operating Officer | 3,177 | $19.32 | $61,380 | 224,066 | −1.40% | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:04 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 3,177 | $19.32 | $61,380 | 63,414 | −4.77% | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:03 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,956 | $19.32 | $57,110 | 58,233 | −4.83% | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:02 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 1,997 | $19.32 | $38,582 | 41,575 | −4.58% | plan? |
| Aug 16, 2017 SForm 4 → | Aug 18, 7:01 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 1,701 | $19.32 | $32,863 | 31,102 | −5.19% | plan? |
| Aug 10, 2017 PForm 4 → | Aug 14, 9:07 am EDT | Roy A WhitfieldDirector | 35,000 | $17.95 | $628,250 | 133,000 | +35.7% | plan? |
| Jul 18, 2017 SForm 4 → | Jul 20, 5:08 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 54,920 | $21.10 | $1,158,812 | 43,572 | −55.8% | plan? |
| Jul 18, 2017 MForm 4 → | Jul 20, 5:08 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 54,920 | $11.04 | $606,317 | 98,492 | — | plan? |
| Jul 14, 2017 SForm 4 → | Jul 18, 8:02 pm EDT | Lutz LingnauDirector | 30,000 | $20.76 | $622,800 | 23,450 | −56.1% | plan? |
| Jul 14, 2017 MForm 4 → | Jul 18, 8:02 pm EDT | Lutz LingnauDirector | 30,000 | $14.26 | $427,800 | 53,450 | — | plan? |
| Jul 11, 2017 SForm 4 → | Jul 13, 8:01 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 45,080 | $21.08 | $950,318 | 43,572 | −50.9% | plan? |
| Jul 11, 2017 MForm 4 → | Jul 13, 8:01 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 45,080 | $11.04 | $497,683 | 80,263 | — | plan? |
| Jun 26, 2017 MForm 4 → | Jun 28, 6:05 pm EDT | Joseph J KrivulkaDirector | 15,000 | $8.37 | $125,550 | 73,000 | — | plan? |
| Jun 7, 2017 SForm 4 → | Jun 9, 6:02 pm EDT | John NicholsonSVP & Chief Operating Officer | 101,700 | $19.24 | $1,956,708 | 227,243 | −30.9% | plan? |
| Jun 7, 2017 MForm 4 → | Jun 9, 6:02 pm EDT | John NicholsonSVP & Chief Operating Officer | 150,000 | $6.34 | $951,000 | 328,943 | — | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:50 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 2,651 | $19.55 | $51,827 | 52,986 | −4.76% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:50 pm EDT | Howard W RobinPresident & CEO, Director | 8,388 | $19.55 | $163,985 | 160,884 | −4.96% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:49 pm EDT | John NicholsonSVP & Chief Operating Officer | 3,146 | $19.55 | $61,504 | 178,943 | −1.73% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:48 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 3,179 | $19.55 | $62,149 | 66,091 | −4.59% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:47 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,959 | $19.55 | $57,848 | 60,689 | −4.65% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:46 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 1,450 | $19.55 | $28,348 | 43,572 | −3.22% | plan? |
| May 16, 2017 SForm 4 → | May 18, 8:45 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 1,701 | $19.55 | $33,255 | 32,803 | −4.93% | plan? |
| May 15, 2017 SForm 4 → | May 17, 6:02 pm EDT | Robert ChessDirector | 5,000 | $19.79 | $98,950 | 271,623 | −1.81% | plan? |
| May 15, 2017 MForm 4 → | May 17, 6:02 pm EDT | Robert ChessDirector | 5,000 | $8.37 | $41,850 | 276,623 | — | plan? |
| Apr 17, 2017 SForm 4 → | Apr 19, 7:30 pm EDT | Robert ChessDirector | 5,000 | $18.72 | $93,600 | 271,623 | −1.81% | plan? |
| Apr 17, 2017 MForm 4 → | Apr 19, 7:30 pm EDT | Robert ChessDirector | 5,000 | $8.37 | $41,850 | 276,623 | — | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 6:04 pm EDT | Lutz LingnauDirector | 7,000 | $20.05 | $140,350 | 23,450 | −23.0% | plan? |
| Apr 5, 2017 SForm 4 → | Apr 7, 6:07 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 100,000 | $21.70 | $2,170,000 | 34,504 | −74.3% | plan? |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:07 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 100,000 | $9.53 | $953,000 | 134,504 | — | plan? |
| Apr 5, 2017 SForm 4 → | Apr 7, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 180,000 | $21.70 | $3,906,000 | 63,648 | −73.9% | plan? |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:05 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 180,000 | $13.70 | $2,466,000 | 243,648 | — | plan? |
| Apr 5, 2017 SForm 4 → | Apr 7, 6:01 pm EDT | Christopher A KueblerDirector | 15,000 | $21.88 | $328,200 | 35,500 | −29.7% | plan? |
| Apr 5, 2017 MForm 4 → | Apr 7, 6:01 pm EDT | Christopher A KueblerDirector | 15,000 | $8.37 | $125,550 | 50,500 | — | plan? |
| Mar 20, 2017 SForm 4 → | Mar 22, 6:04 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 112,500 | $19.69 | $2,215,125 | 55,637 | −66.9% | plan? |
| Mar 20, 2017 MForm 4 → | Mar 22, 6:04 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 112,500 | $9.96 | $1,120,875 | 168,137 | — | plan? |
| Mar 15, 2017 MForm 4 → | Mar 17, 6:02 pm EDT | Roy A WhitfieldDirector | 14,000 | $8.37 | $117,180 | 98,000 | — | plan? |
| Mar 14, 2017 SForm 4 → | Mar 16, 6:02 pm EDT | Robert ChessDirector | 5,000 | $15.41 | $77,050 | 271,623 | −1.81% | plan? |
| Mar 14, 2017 MForm 4 → | Mar 16, 6:02 pm EDT | Robert ChessDirector | 5,000 | $8.37 | $41,850 | 276,623 | — | plan? |
| Mar 2, 2017 SForm 4 → | Mar 3, 7:04 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 200,000 | $15.16 | $3,031,950 | 69,270 | −74.3% | plan? |
| Mar 2, 2017 MForm 4 → | Mar 3, 7:04 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 200,000 | $6.70 | $1,340,500 | 94,270 | — | plan? |
| Feb 21, 2017 SForm 4 → | Feb 23, 6:32 pm EST | Lutz LingnauDirector | 30,000 | $13.08 | $392,400 | 30,450 | −49.6% | plan? |
| Feb 21, 2017 MForm 4 → | Feb 23, 6:32 pm EST | Lutz LingnauDirector | 30,000 | $5.14 | $154,200 | 60,450 | — | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,965 | $13.14 | $25,820 | 55,637 | −3.41% | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:06 pm EST | Howard W RobinPresident & CEO, Director | 8,636 | $13.14 | $113,477 | 169,272 | −4.85% | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:05 pm EST | John NicholsonSVP & Chief Operating Officer | 3,237 | $13.14 | $42,534 | 182,089 | −1.75% | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:04 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 2,359 | $13.14 | $30,997 | 69,270 | −3.29% | plan? |
| Feb 16, 2017 SForm 4 → | Feb 17, 8:04 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,195 | $13.14 | $28,842 | 63,648 | −3.33% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2017 MForm 4 → | Feb 6, 5:20 pm EST | John NicholsonSVP & Chief Operating Officer | 75,000 | — | — | 45,000 | — | |
| Jan 17, 2017 MForm 4 → | Jan 19, 8:01 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 87,500 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:47 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 37,500 | — | — | 37,500 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:46 pm EST | Howard W RobinPresident & CEO, Director | 137,500 | — | — | 137,500 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:45 pm EST | John NicholsonSVP & Chief Operating Officer | 50,000 | — | — | 50,000 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:45 pm EST | Gil M LabrucherieSVP & Chief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:44 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 37,500 | — | — | 37,500 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:43 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 50,000 | — | — | 50,000 | — | |
| Dec 13, 2016 AForm 4 → | Dec 15, 8:42 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 43,750 | — | — | 43,750 | — | |
| Dec 7, 2016 MForm 4 → | Dec 9, 6:03 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 175,000 | — | |
| Nov 17, 2016 MForm 4 → | Nov 18, 6:12 pm EST | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 262,500 | — | |
| Oct 4, 2016 MForm 4 → | Oct 6, 5:07 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 350,000 | — | |
| Sep 23, 2016 MForm 4 → | Sep 27, 5:09 pm EDT | Roy A WhitfieldDirector | 46,000 | — | — | 0 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:14 pm EDT | Dennis L WingerDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:13 pm EDT | Roy A WhitfieldDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:12 pm EDT | Lutz LingnauDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:11 pm EDT | Christopher A KueblerDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:11 pm EDT | Joseph J KrivulkaDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:10 pm EDT | R Scott GreerDirector | 20,000 | — | — | 20,000 | — | |
| Sep 21, 2016 AForm 4 → | Sep 23, 5:09 pm EDT | Robert ChessDirector | 20,000 | — | — | 20,000 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:17 pm EDT | Dennis L WingerDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:16 pm EDT | Roy A WhitfieldDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:16 pm EDT | Lutz LingnauDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:15 pm EDT | Christopher A KueblerDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:14 pm EDT | Joseph J KrivulkaDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:14 pm EDT | R Scott GreerDirector | 15,000 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 19, 5:13 pm EDT | Robert ChessDirector | 15,000 | — | — | 0 | — | |
| Sep 1, 2016 MForm 4 → | Sep 2, 8:03 pm EDT | Howard W RobinPresident & CEO, Director | 87,500 | — | — | 437,500 | — | |
| Aug 1, 2016 MForm 4 → | Aug 3, 7:01 pm EDT | Robert ChessDirector | 5,000 | — | — | 0 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:10 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 68,750 | — | — | 18,750 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:09 pm EDT | Howard W RobinPresident & CEO, Director | 281,250 | — | — | 56,250 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:08 pm EDT | John NicholsonSVP & Chief Operating Officer | 109,500 | — | — | 22,000 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:07 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 109,500 | — | — | 87,500 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:06 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 72,000 | — | — | 22,000 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:05 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 62,500 | — | — | 12,500 | — | |
| Jul 14, 2016 AForm 4 → | Jul 18, 5:04 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 58,750 | — | — | 8,750 | — | |
| Jul 11, 2016 MForm 4 → | Jul 13, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 100,000 | — | — | 0 | — | |
| Jul 1, 2016 MForm 4 → | Jul 5, 5:21 pm EDT | Robert ChessDirector | 5,000 | — | — | 5,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 5:07 pm EDT | John NicholsonSVP & Chief Operating Officer | 100,000 | — | — | 100,000 | — | |
| Jun 1, 2016 AForm 4 → | Jun 3, 5:06 pm EDT | Gil M LabrucherieSVP & Chief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Jun 1, 2016 MForm 4 → | Jun 3, 5:05 pm EDT | Robert ChessDirector | 5,000 | — | — | 10,000 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:23 pm EDT | John NicholsonSVP & Chief Financial Officer | 2,167 | — | — | 21,667 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:23 pm EDT | Howard W RobinPresident & CEO, Director | 5,625 | — | — | 56,250 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:15 pm EDT | Stephen K DobersteinSVP & Chief Scientific Officer | 875 | — | — | 8,750 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:14 pm EDT | Ivan P. GergelSVP & Chief Medical Officer | 1,250 | — | — | 12,500 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:13 pm EDT | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,167 | — | — | 21,667 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:12 pm EDT | Gil M LabrucherieSVP & General Counsel | 2,167 | — | — | 21,667 | — | |
| May 16, 2016 DForm 4 → | May 18, 5:08 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,875 | — | — | 18,750 | — | |
| Apr 25, 2016 MForm 4 → | Apr 27, 5:08 pm EDT | Lutz LingnauDirector | 15,000 | — | — | 0 | — | |
| Mar 9, 2016 MForm 4 → | Mar 11, 5:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 0 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:49 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 1,250 | — | — | 13,750 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:48 pm EST | John NicholsonSVP & Chief Financial Officer | 2,166 | — | — | 23,834 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:48 pm EST | Howard W RobinPresident & CEO, Director | 5,625 | — | — | 61,875 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:47 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 875 | — | — | 9,625 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:46 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 1,875 | — | — | 20,625 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:45 pm EST | Gil M LabrucherieSVP & General Counsel | 2,166 | — | — | 23,834 | — | |
| Feb 16, 2016 DForm 4 → | Feb 18, 7:45 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 2,166 | — | — | 23,834 | — | |
| Feb 10, 2016 MForm 4 → | Feb 12, 5:20 pm EST | Gil M LabrucherieSVP & General Counsel | 11,666 | — | — | 0 | — | |
| Feb 10, 2016 MForm 4 → | Feb 12, 5:19 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 15,000 | — | |
| Feb 10, 2016 MForm 4 → | Feb 12, 5:18 pm EST | Howard W RobinPresident & CEO, Director | 66,666 | — | — | 0 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:12 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Jan 20, 2016 MForm 4 → | Jan 21, 6:04 pm EST | Lutz LingnauDirector | 15,000 | — | — | 0 | — | |
| Jan 19, 2016 MForm 4 → | Jan 21, 6:06 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 30,000 | — | |
| Jan 19, 2016 MForm 4 → | Jan 21, 6:05 pm EST | Howard W RobinPresident & CEO, Director | 66,667 | — | — | 66,666 | — | |
| Jan 19, 2016 MForm 4 → | Jan 21, 6:02 pm EST | Gil M LabrucherieSVP & General Counsel | 11,667 | — | — | 11,666 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:45 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 48,000 | — | — | 22,000 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:44 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 41,250 | — | — | 18,750 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:44 pm EST | Gil M LabrucherieSVP & General Counsel | 48,000 | — | — | 22,000 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:43 pm EST | John NicholsonSVP & Chief Financial Officer | 48,000 | — | — | 22,000 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:42 pm EST | Howard W RobinPresident & CEO, Director | 123,750 | — | — | 56,250 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:41 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 27,500 | — | — | 12,500 | — | |
| Dec 15, 2015 AForm 4/A → | Jan 15, 2016, 4:41 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 19,250 | — | — | 8,750 | — | |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:47 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 41,250 | — | — | 22,500 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:47 pm EST | Howard W RobinPresident & CEO, Director | 123,750 | — | — | 67,500 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:46 pm EST | John NicholsonSVP & Chief Financial Officer | 48,000 | — | — | 26,000 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:44 pm EST | Gil M LabrucherieSVP & General Counsel | 48,000 | — | — | 26,000 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:43 pm EST | Maninder HoraSVP Pharma Dev & Mfg Ops | 48,000 | — | — | 26,000 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:43 pm EST | Ivan P. GergelSVP & Chief Medical Officer | 27,500 | — | — | 15,000 | — | amended |
| Dec 15, 2015 AForm 4 → | Dec 17, 6:42 pm EST | Stephen K DobersteinSVP & Chief Scientific Officer | 19,250 | — | — | 10,500 | — | amended |
| Dec 4, 2015 MForm 4 → | Dec 7, 5:31 pm EST | Christopher A KueblerDirector | 15,000 | — | — | 0 | — | |
| Dec 3, 2015 MForm 4 → | Dec 7, 5:36 pm EST | Gil M LabrucherieSVP & General Counsel | 45,001 | — | — | 23,333 | — | |
| Dec 3, 2015 MForm 4 → | Dec 7, 5:33 pm EST | Howard W RobinPresident & CEO, Director | 125,001 | — | — | 133,333 | — | |
| Dec 3, 2015 MForm 4 → | Dec 7, 5:29 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 45,000 | — | |
| Nov 18, 2015 MForm 4 → | Nov 20, 5:27 pm EST | Susan WangDirector | 85,000 | — | — | 0 | — | |
| Nov 11, 2015 MForm 4 → | Nov 13, 5:41 pm EST | Howard W RobinPresident & CEO, Director | 125,000 | — | — | 200,000 | — | |
| Nov 11, 2015 MForm 4 → | Nov 13, 5:35 pm EST | Gil M LabrucherieSVP & General Counsel | 45,000 | — | — | 35,000 | — | |
| Nov 11, 2015 MForm 4 → | Nov 13, 4:12 pm EST | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 60,000 | — | |
| Oct 28, 2015 MForm 4 → | Oct 30, 4:17 pm EDT | Lutz LingnauDirector | 12,500 | — | — | 0 | — | |
| Oct 15, 2015 MForm 4 → | Oct 19, 5:01 pm EDT | R Scott GreerDirector | 32,500 | — | — | 0 | — | |
| Oct 6, 2015 MForm 4 → | Oct 8, 7:12 pm EDT | Howard W RobinPresident & CEO, Director | 125,000 | — | — | 266,667 | — | |
| Oct 6, 2015 MForm 4 → | Oct 8, 7:11 pm EDT | Gil M LabrucherieSVP & General Counsel | 45,000 | — | — | 46,667 | — | |
| Oct 6, 2015 MForm 4 → | Oct 8, 7:09 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 15,000 | — | — | 75,000 | — | |
| Sep 23, 2015 MForm 4 → | Sep 25, 5:25 pm EDT | Jillian B. ThomsenSVP & Chief Accounting Officer | 10,000 | — | — | 90,000 | — | |
| Sep 23, 2015 MForm 4 → | Sep 25, 5:24 pm EDT | Howard W RobinPresident & CEO, Director | 124,999 | — | — | 333,334 | — | |
| Sep 23, 2015 MForm 4 → | Sep 25, 5:22 pm EDT | Gil M LabrucherieSVP & General Counsel | 44,999 | — | — | 58,334 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:25 pm EDT | Dennis L WingerDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:24 pm EDT | Roy A WhitfieldDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:23 pm EDT | Susan WangDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:22 pm EDT | Lutz LingnauDirector | 27,500 | — | — | 15,000 | — | |
| Sep 15, 2015 AForm 4 → | Sep 17, 5:21 pm EDT | Christopher A KueblerDirector | 27,500 | — | — | 15,000 | — |